Summit Cancer Centers Founder and Medical DirectorDr. Arvind Chaudhrywill chair theCoeur d'Alene Hematology Oncology ConferenceonOctober 11, 2025, at the Coeur d'Alene Resort. The continuing medical education (CME) event will focus onprecision-guided management in oncology, offering6.0 CME credits, MOC II points, and ACPE creditsfor participating clinicians.
The conference, part of the nationally recognizedBinaytara CME Conference Series, has become a cornerstone of regional medical education. Founded in collaboration withDr. Binay Shah, president and co-founder of theBinaytara Foundation,the series began in 2015 as a small gathering reviewing ASCO and ASH highlights. It has since evolved into a leading annual event drawing oncology professionals from across the country.
“Our goal is to have a healthy discussion and not just a lecture,” said Dr. Chaudhry. “We want all cancer-treating doctors-medical oncologists, radiation oncologists, and surgical oncologists-involved, almost like a tumor board format.”
Dr. Chaudhry will also chair thelung cancer session, a timely focus as the field continues to evolve with a surge ofFDA approvals for targeted and immune therapies.”It is very exciting, the number of drugs now approved every year,” he said. “Treatments that were once tested in advanced disease are now being used earlier, both before and after surgery. Those are major advances.”
Dr. Chaudhry's leadership extends beyond education to advancingclinical research in community settings.His recent participation in theArtistry-1 trialtested a novel immunotherapy for melanoma and renal cell carcinoma and demonstrates the impact of expanding access to early-phase trials locally. The study provided a safer alternative to older IL-2 treatments, highlighting the potential for groundbreaking research outside large academic centers.
“Summit Cancer Centers is committed to closing the gap between discovery and delivery,” Dr. Chaudhry said. “By combining clinical research with education, we ensure that new treatments reach patients faster and more effectively.”
The Coeur d'Alene conference embodies this vision, bringing together community oncologists and leading experts from institutions includingSeattle, Portland, and Stanfordfor practical, case-based discussions designed to improve outcomes across the region.
For details about the Coeur d'Alene Hematology Oncology Conference, visitbinaytara.org/conferences.
To learn more about Summit Cancer Centers, visit summitcancercenters.com.
Media Inquiries/Contact:John DriscollSummit Cancer Centers509-462-2273402447@email4pr.com
https://edge.prnewswire.com/c/img/favicon.png?sn=PH93916&sd=2025-10-09
View original content to download multimedia:https://www.prnewswire.com/news-releases/summit-cancer-center-director-arvind-chaudhry-md-phd-to-chair-coeur-dalene-hematology-oncology-conference-focused-on-precision-guided-cancer-care-302579325.html
SOURCE Summit Cancer Centers
https://rt.newswire.ca/rt.gif?NewsItemId=PH93916&Transmission_Id=202510090836PR_NEWS_USPR_____PH93916&DateId=20251009